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Polymorphismsa b s t r a c t
Feline immunodeﬁciency virus (FIV) and feline leukemia virus (FeLV) are widely distributed retroviruses
that infect domestic cats (Felis catus). Restriction factors are proteins that have the ability to hamper
retroviruses’ replication and are part of the conserved mechanisms of anti-viral immunity of mammals.
The APOBEC3 protein family is the most studied class of restriction factors; they are cytidine deaminases
that generate hypermutations in provirus DNA during reverse transcription, thus causing hypermutations
in the viral genome, hindering virus replication. One of the feline APOBEC3 genes, named APOBEC3H,
encodes two proteins (APOBEC3H and APOBEC3CH). In other mammals, APOBEC3H single-nucleotide
polymorphisms (SNPs) can alter the stability and cellular localization of the encoded protein, thus
inﬂuencing its subcellular localization and reducing its anti-viral effect. In cats, the association of
APOBEC3H SNPs with susceptibility to retroviral infections was not yet demonstrated. Therefore, this
study aimed the investigation on the variability of APOBEC3H and the possible association with FIV/FeLV
infections. DNA obtained from whole blood of ﬁfty FIV- and/or FeLV-infected cats and ﬁfty-nine FIV- and/
or FeLV-uninfected cats were used as templates to amplify two different regions of the APOBEC3H, with
subsequent sequencing and analysis. The ﬁrst region was highly conserved among all samples, while in
the second, six single-nucleotide variation points were identiﬁed. One of the SNPs, A65S (A65I), was
signiﬁcantly correlated with the susceptibility to FIV and/or FeLV infections. On the other hand, the
haplotype analysis showed that the combination ‘‘GGGGCC’’ was positively correlated with the lack of
FIV and/or FeLV infections. Our results indicate that, as previously shown in other mammals, variability
of restriction factors may contribute to susceptibility of domestic cats to retroviral infections; however,
these results should be conﬁrmed by more extensive analysis and in vitro experiments.
 2014 Elsevier B.V. All rights reserved.1. Introduction
The feline immunodeﬁciency virus (FIV) is a lentivirus that
belongs to the Retroviridae family. This virus is widely distributed
among domestic cats and induces an important immunosuppressive
effect upon infection (Lutz, 1990, pp. 131–146). The last stage ofFIV infection is characterized by an acquired immunodeﬁciency
syndrome, named feline acquired immunodeﬁciency syndrome—
FAIDS (Goto et al., 2000), which is similar to that seen in humans
infected with the human immunodeﬁciency virus (HIV). The
outcome of FIV infections is variable, and death occurs in approx-
imately 18% of infected animals within the ﬁrst 2 years of infection
(Barr, 2000, pp. 433–438).
The feline leukemia virus (FeLV) belongs to the genus Gamma-
retrovirus, within the family Retroviridae. Like FIV, FeLV is also a
worldwide, cosmopolitan distributed virus, which is associated
Fig. 1. Schematic structure of the feline A3H gene. The exons are represented by the
gray boxes, and the introns are represented by the black lines. The ﬁrst targeted
region corresponds to the initial 300 bp of the translated portion of the gene, and
the second one corresponds to a 590 bp product, corresponding to exon 3 and part
of introns 2 and 3.
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proliferative syndromes in domestic cats (Costa et al., 2000;
Cotter, 1991; Pontier et al., 1998). For a long time, FeLV was
considered to account for most tumoral disease-related deaths,
and it was responsible for more clinical syndromes than any other
single agent in cats (Hartmann, 2012).
In addition to innate and adaptive immune responses to viruses,
humans and other mammals produce speciﬁc anti-retroviral pro-
teins that interact with virions during their replication, blocking
the completion of the virus replication cycle (Berthoux et al.,
2005; Kirchhoff, 2010; Virgen and Hatziioannou, 2007). They are
highly conserved proteins, named restriction factors, which are
constitutively expressed in some cellular types and/or interferon-
induced cells (Berthoux et al., 2005; Kirchhoff, 2010; Virgen and
Hatziioannou, 2007).
The apolipoprotein B mRNA editing enzyme catalytic polypep-
tide 3 (APOBEC3 or A3) genes encode the most studied class of
restriction factors, which belongs to the superfamily of cytidine
deaminases (Stremlau et al., 2004; Wedekind et al., 2003). These
genes are found in different numbers in mammals; while primates
contains seven of these genes (A3A to A3H), the cat genome
presents one A3H gene and three A3C genes. Of these four, only
the A3H product displays anti-retroviral activity (Münk et al.,
2008). In addition to these, a ﬁfth transcript, designated A3CH, is
expressed by read-through alternative splicing, and its product
was also shown to restrict feline retroviruses (Münk et al., 2008).
The latter is the most evolutionary divergent member of the A3
family (Conticello et al., 2005). The A3H gene is organized in ﬁve
exons. The ﬁrst is a noncoding exon. The second and third exons
fall in the region that code the catalytic motifs, characterized by
the following sequence: His-X-Glu-X23–28-Pro-Cys-X2–4-Cys
(Jarmuz et al., 2002; Münk et al., 2008).
A3 proteins act in retroviruses by deaminating cytidine into
uridine in the minus-sense single-strand viral DNA, which results
in the extensive G-to-A hypermutations in the plus-strand viral
DNA (Bishop et al., 2004; Dang et al., 2006; Luo et al., 2004;
Schäfer et al., 2004). In addition to the resulting high levels of
mutations, deamination-independent mechanisms, e.g., interfer-
ence on the reverse transcription process (Sakai et al., 2006), also
add to the anti-viral effect of A3 proteins (Wedekind et al., 2003).
On its turn, FIV evolved the viral infectivity factor (Vif) protein,
whose function is to counteract the A3 proteins effect (Münk
et al., 2008). Vif interacts with these restriction factors and trig-
gers their ubiquitination and degradation via the proteasomal
pathway (Bishop et al., 2004; Dang et al., 2006; Luo et al.,
2004; Münk et al., 2008). As a consequence, the replication of
Vif-deﬁcient FIV (DvifFIV) is highly restricted (Münk et al.,
2008). Although the feline A3H displays activity against DvifFIV,
its effect on FeLV replication is barely marginal (REFS). A3CH
was also shown to display a pronounced antiretroviral activity
against DvifFIV and FeLV, also by generating hypermutations
(Münk et al., 2008).
In humans, A3 haplotypes are distributed differently among
individuals of Asian, European, and African origin. The different
genetic backgrounds in allele frequencies and haplotype architec-
ture observed among different populations may inﬂuence the out-
come of HIV infection and progression of disease (An et al., 2004;
Bizinoto et al., 2011; Harari et al., 2009). Different reports have
analyzed the effect of A3 single-nucleotide polymorphisms (SNPs)
on the susceptibility of human subjects to HIV infection and
progression. Indeed, some SNPs, which may alter the level of A3
activity or expression, are associated with a higher or lower risk
of HIV infection (An et al., 2004; Bizinoto et al., 2011; Harari
et al., 2009). In felines, there are no such reports, even though
the importance of A3 proteins in feline retroviruses restriction
is unequivocal.2. Theory
Once the A3H protein shows a restrictive role against feline
retroviruses, our objective is to search for polymorphisms in two
genomic regions of the A3H of FIV- and/or FeLV-infected as well
as uninfected domestic cats. In addition, we aim to identify a
possible association between variations in this gene with suscepti-
bility to infection.3. Materials and methods
3.1. DNA samples
DNA samples were extracted from peripheral blood of domestic
cats collected at the Hospital de Clínicas Veterinárias/Universidade
Federal do Rio Grande do Sul (UFGRS). The blood samples were
derived from male and female cats, with ages ranging from
1 month to 13 years old, who were displaying different clinical
syndromes suspected of FIV and/or FeLV infections. These animals
are outdoor, non-pedigree cats, characterized as a genetically
homogeneous population. Blood samples were stored individually
in tubes and kept refrigerated during transport to the Virology Lab-
oratory of UFRGS, where DNA was extracted using buffer-saturated
phenol and submitted to two polymerase chain reactions (PCRs) to
detect provirus DNA based on the ampliﬁcation of the gag region of
the virus genome (unpublished data). Brieﬂy, to detect FIV gen-
omes, the ampliﬁcation reaction targeted a conserved region of
the gene gag using the primers (IDT) FIVF 50-AAAATGGTGTC-
CATTTTTATGG-30 and FIVR 50-GCTTCTGCTTGTTGTTCTTG-30. To
detect FeLV genomes, the ampliﬁcation reactions targeted a con-
served region of the gag gene using the primers FeLVF 50-AACTAAC-
CAATCCCCACGC-30 and FeLVR 50-AATGGCTGTCCCACTAGAG-30. The
primers used in the PCR assays were originally designed to avoid
annealing to endogenous retroviruses’ sequences.
The sensitivity of the PCRs was determined by titration of inter-
nal control (IC) templates (DNA fragments that are ampliﬁed with
the same primers and under the same PCR conditions). Both FIV
and FeLV PCRs were able to detect between 25 and 250 IC
molecules, implying that the lower detection limit of these PCRs
was about 25 IC molecules (unpublished data).
In total, 50 positive samples (comprising 18 FIV-positive, 15
FeLV-positive, and 17 positive for both viruses) and 59 samples
from uninfected animals were obtained and used in the present
study.3.2. Determination of polymorphisms in the APOBEC3H gene
All of the DNA samples were used as templates to amplify two
different regions of the A3H gene. The ﬁrst region comprises the
ﬁrst 300 bp of the translated portion of the gene. The second tar-
geted region corresponds to a 590 bp product between nucleotides
707–1296, comprehending exon 3 and part of introns 2 and 3
(Fig. 1). According to previously published data, both regions
analyzed here correspond to portions of the A3H transcript that
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tant for the antiviral activity of the protein. This was the main rea-
son that we chose these regions for our analysis.
The primers used in the present study for ampliﬁcation of both
regions of the A3H gene are shown in Table 1. The PCRs were opti-
mized and performed in ﬁnal volumes of 25 ll. For both the ﬁrst
and the second targeted regions, the initial cycle consisted of a
denaturation step at 95 C for 5 min, followed by 35 cycles at
95 C for 30 s (denaturation), 55 C for 30 s (annealing), and 72 C
for 30 s (extension). An additional extension step at 72 C for
3 min was applied.
The amplicons obtained were subsequently sequenced, and the
sequences were aligned using BioEdit and SeqMan (DNAStar
software). The genotype and allele frequencies were determined
by the gene counting method (meaning that the samples’
genotypes were determined manually), and the Hardy–Weinberg
equilibrium was calculated.
3.3. Genotype analysis of the haplotypes
The obtained sequences were submitted to analysis of the
haplotypes using the MLOCUS program for determination of
haplotypes (Long et al., 1995). The frequencies of the haplotypes
were determined with the aid of the software DnaSP (Librado
and Rozas, 2009). The linkage equilibrium was also calculated for
the loci involved.
3.4. Statistical analysis
In order to search for the potential correlation between the
frequencies of polymorphisms, haplotypes and susceptibility to
infection by FIV and FeLV, the Person chi-square test (v2), and
Fisher’s exact test (when n < 5) were performed between groups
of positive and negative animals. The group of positive
samples was analyzed as a single FIV- and/or FeLV-infected set of
animals and as two groups of FIV- or FeLV-positive animals. All
mentioned analyses were performed using SPSS v.17 software. For
tests that provided signiﬁcant results (p < 0.05), an adjusted residual
analysis was performed using the program WinPepi v.11:32.4. Results
4.1. Identiﬁcation of A3H variants
Both regions of the A3H gene were successfully ampliﬁed in all
samples. No single polymorphism was found in the ﬁrst targeted
region ampliﬁed from all samples (approximately 300 bp). Within
the second targeted region, 450 bp were analyzed. Six SNPs were
identiﬁed in this region, ﬁve in exon 3 and one located in intron
3. These polymorphisms were named A65S (A65I), R68Q, A94T,
V96I, P100P, and 134698145T>C. The ﬁrst SNP, A65S (A65I), may
display a guanine (G), a thymine (T), or an adenine (A) in the ﬁrst
position of the codon. The reference sequence displays a G in that
position, leading to the translation of the amino acid alanine atTable 1
Primers and PCR products. Primers used to amplify the targeted regions of the A3H
gene and their expected amplicon sizes.
Regions Primers Amplicon size
1 Forward = 50-ACACCAGAAGACACTCTCTGC-30 401 bp
Reverse = 50-CCTCTTGGCTTCTCAGAAACG-30
2 Forward = 50-TCATCCCCAATGGCACCCACAGC-30 589 bp
Reverse = 50-TCAAACTCTGAGACGGAGGAGGAG-30position 65. Substitution of the G for a T leads to the expression
of a serine in that position. In turn, the change to nucleotide
A is always accompanied by a T at the next position, and this
combination codiﬁes the amino acid isoleucine. The amount and
frequency of each genotype found in the studied population are
presented in Table 2.
4.2. Analysis of the correlation between the alleles and genotypes with
the susceptibility to retroviral infection
Following the analysis of the six polymorphisms and their
respective genotypes, a positive correlation was found between
the polymorphism at position 65 (A65S or A65I) and the presence
of viral infection (p 6 0.05) (Table 2).
The analysis of residues revealed that genotype ‘‘TT’’ was
positively correlated with the detection of FIV and/or FeLV in the
clinical samples. This result was observed both when the samples
of positive animals were analyzed together (when single FIV or
FeLV positive samples and samples from co-infected animals were
grouped) and separately (splitting into two groups of cats infected
with FIV or FeLV). The genotype ‘‘TA’’ was also signiﬁcantly
correlated with infection; however, they were only signiﬁcantly
correlated when animals positive for FIV and/or FeLV were
analyzed as a single group, not when FIV or FeLV positive animals
were analyzed separately. The other polymorphisms found here
were not signiﬁcantly correlated with FIV or FeLV infection. These
data are summarized in Table 3.
4.3. Analysis of the haplotypes found in the population and their
correlation with susceptibility to FIV and/or FeLV infections
A total of ten distinct haplotypes were observed in the 109 sam-
ples examined in the present study. The occurrence of such haplo-
types was evident in both chromosomes of the sampled animals,
totalizing 218 haplotypes. Haplotype ‘‘GGGGCT’’ was predomi-
nantly found in the sampled animals (101 times, Table 4). The cal-
culated linkage disequilibrium between polymorphisms indicated
that all loci segregate together (values of D0 < 0.33). Combinations
present in the population as well as their total frequency in the
FIV- and/or FeLV-positive or -negative populations are shown in
Table 4. An association between the presence of the haplotype
‘‘GGGGCC’’ and the absence of viral infection was observed, as this
combination was found in a signiﬁcantly higher frequency in
uninfected animals when compared to FIV- and/or FeLV-infected
animals (Table 4).5. Discussion
According to previously published data, there is strong evidence
that the feline A3H gene codes not only one but two proteins with
proven antiviral function, named A3H and A3CH proteins. These
proteins play an important role as restriction factors of FIV and
FeLV infection, inducing deleterious hypermutations to nascent
virions (Münk et al., 2008; Löchelt et al., 2005; Zielonka et al.,
2012). Moreover, it is also known that the A3H gene is present in
several other species and is conserved in mammals (Münk et al.,
2012). These ﬁndings highlight the importance of A3H products
as restrictive factors of FIV and FeLV infections in their main hosts.
Only a few sequences related to the A3H gene from domestic
cats are available in the literature; in addition, few have been ana-
lyzed for diversity (Münk et al., 2008). The present study aimed to
widen the study on the diversity of the A3H gene in FIV- and/or
FeLV-infected and uninfected domestic cats, attempting to under-
stand the effect of such diversity on the susceptibility to FIV and
or FeLV infections.
Table 3
Residual analysis of polymorphism S65A (S65I). (A) Residual analysis of polymorphism S65A (S65I) found among FIV- and/or FeLV-infected and uninfected animals. (B) Residual
analysis of polymorphism S65A (S65I) found among FIV infected and uninfected animals. (C) Residual analysis of polymorphism S65A (S65I) found among FeLV-infected and
uninfected animals.
Polymorphism Genotype FIV and/or FeLV infected animals (n = 50) Uninfected animals (n = 59) p-Value
(A) A65S (A65I) TT 13 5 0.014⁄
TG 21 27 0.693
TA 0 5 0.035⁄
GG 14 21 0.398
GA 2 1 0.464
FIV-infected animals (n = 35) FIV uninfected (n = 74)
(B) A65S (A65I) TT 10 8 0.020⁄
TG 14 34 0.559
TA 0 5 0.115
GG 9 26 0.325
GA 2 1 0.194
FeLV-infected animals (n = 32) FeLV uninfected animals (n = 78)
(C) A65S (A65I) TT 11 7 0.001⁄
TG 11 37 0.257
TA 0 5 0.149
GG 9 26 0.664
GA 0 3 0.268
Table 2
Polymorphisms, genotypes and frequencies. Number, frequencies, and correlation between the genotypes found for each SNP among FIV- and/or FeLV-infected and uninfected
domestic cats.
Polymorphism Codons Genotypes FIV- and/or FeLV-infected animals (n = 50) FIV and FeLV uninfected animals (n = 59) p-Value
TCA/TCA TT 13 (26%) 5 (8, 5%)
TCA/GCA TG 21 (42%) 27 (45, 7%)
A65S (A65I) TCA/ATA TA 0 (0%) 5 (8, 5%) 0.035⁄
GCA/GCA GG 14 (28%) 21 (35, 6%)
GCA/ATA GA 2 (4%) 1 (1, 7%)
CAG/CAG AA 2 (4%) 2 (3, 45%)
R68Q CAG/CGG AG 5 (10%) 8 (13, 5%) 0.758
CGG/CGG GG 43 (86%) 49 (83%)
ACG/ACG AA 2 (4%) 2 (3, 45%)
A94T ACG/GCG AG 5 (10%) 8 (13, 5%) 0.758
GCG/GCG GG 43 (86%) 49 (83%)
ATC/GTC AG 7 (14%) 4 (6, 8%)
V96I GTC/GTC GG 43 (86%) 55 (93, 2%) 0.212
CCC/CCT CT 7 (14%) 4 (6, 8%)
P100P CCC/CCC CC 43 (86%) 55 (93, 2%) 0.212
TT 18 (36%) 18 (30, 5%)
134698145T>C – CT 14 (28%) 25 (42, 4%) 0.287
CC 18 (36%) 16 (27, 1%)
⁄ p  0.05.
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A3H gene of FIV- and/or FeLV-infected or uninfected cats, which
we then sequenced and analyzed. An analysis of possible correla-
tions between the presence of SNPs and FIV/FeLV infections was
performed and quoted with the results of FIV-/FeLV-negative sam-
ples. The ﬁrst targeted region of the A3H gene was found here
highly conserved, while in the second targeted region, it was pos-
sible to identify six SNPs. According to the database of the NCBI
(GenBank accession number: ABO82576.1), both regions analyzed
here contain portions that are part of the catalytic deamination
domain (critical to generate hypermutations in the viral genome)
(Münk et al., 2008). The ﬁrst region codes many residues related
to the active sites within this domain. Residues at these positions
were identical among all sequences analyzed (e.g., residues 27,
29, 47, and 49; Münk et al., 2008). The lack of genomic variation
observed in this region is probably due to the role that these amino
acids display in the protein function. In addition, as shown in pre-
vious studies, a D15 deletion found in the N-terminal region of
human A3H, homologous to the ﬁrst region of our study, was
responsible for the loss of function of this protein in a portion of
the population during recent human evolution (OhAinle et al.,2008). These ﬁndings indicate that few changes are tolerated in
this region and possibly corroborate with the lack of variability
observed in the region.
When the six SNPs found in the second targeted region of A3H
are analyzed in detail, it was observed that the A65S replacement
was correlated with a greater susceptibility to infection with FIV
and FeLV when the genotype ‘‘TT’’ is displayed (p = 0.014). In that
case, the animal encodes an alanine in both copies of the gene.
The SNP A65I, concomitantly with A65S, generated by the geno-
type ‘‘TA,’’ also correlated signiﬁcantly (p = 0.035) with the suscep-
tibility to infection but only when the FIV- and/or FeLV-positive
samples were analyzed as a single group. The low frequency of this
genotype (TA) may explain why this correlation was not detected
when the two viruses were analyzed separately. Thus, a more
robust study with a larger number of analyzed animals may
conﬁrm these ﬁndings. However, the proximity of the residue 65
with important residues within the catalytic site—62, 63, 64, and
66 (Münk et al., 2008)—may help to explain the correlation
between the amino acid exchange and susceptibility to infection.
It is well known that amino acid exchanges, especially when they
display different properties, can affect the three-dimensional
Table 4
Haplotypes and frequencies. Main haplotypes found in the studied population, their frequencies within groups according to the diagnostic for FIV/FeLV infections and their
correlation between the haplotypes with the susceptibility to retroviral infection.
Haplotype FIV and/or FeLV positive or negative samples N Frequency p Value
+ 
Freq Freq
AGGGCC 1 6 7 0.03211009 0.118
0.01 0.051
TGGGCT 3 2 5 0.02293578 0.663
0.03 0.017
AGGGCT 1 0 1 0.00458716 0.459
0.01 0
GGGATC 2 0 2 0.00917431 0.209
0.02 0
GGGGCC 4 15 19 0.08715596 0.023⁄
0.04 0.127
TGGATC 5 4 9 0.0412844 0.735
0.05 0.034
GGGGCT 46 55 101 0.46330275 0.928
0.46 0.466
TGGGCC 29 24 53 0.24311927 0.137
0.29 0.203
TAAGCC 8 12 20 0.09174312 0.580
0.08 0.102
TAGGCC 1 0 1 0.00458716 0.459
0.01 0
Total 100 118 218 1 –
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exchange of the nonpolar amino acid alanine to the neutral polar
amino acid serine). A change of amino acids at the position 65 of
A3H had already been observed in other feline species, such as
the Indochinese tiger (Münk et al., 2008), indicating that this posi-
tion may be more variable than others.
Finally, although there are residues in the second region that do
participate in the catalytic domain of A3H, the polymorphisms
found in this study do not correspond to any residue within the
active sites, which possibly allows a greater genetic variation in
that region.
The analysis of the haplotypes displayed in the sampled popu-
lation revealed ten different combinations. Haplotype ‘‘GGGGCT’’
was the most frequently detected (0.46), followed by ‘‘TGGGCC’’
(0.24), while other haplotypes were detected at much lower fre-
quencies (Table 4). These results may be explained by the fact that
the six polymorphisms were segregating together in linkage dis-
equilibrium. In humans, certain A3H haplotypes inﬂuence both
the activity of the protein and their subcellular location (OhAinle
et al., 2008; Li and Emerman, 2011; Harari et al., 2009). Some of
these haplotypes encode a completely inactive A3H, thus promot-
ing retroviral infections in the subjects that display such haplo-
types (OhAinle et al., 2008; Li and Emerman, 2011; Harari et al.,
2009). In the present study, the haplotype ‘‘GGGGCC’’ was signiﬁ-
cantly more frequently detected in the FIV- and FeLV-uninfected
animals, suggesting a possible protective effect of this allelic com-
bination in relation to infection by FIV and FeLV. Interestingly,
according to the ﬁndings above, this combination does not have
the genotype ‘‘TT’’ or ‘‘TA’’ in the ﬁrst position, which, at ﬁrst,
seems to confer increased susceptibility to infection by FIV and/
or FeLV.
The genotype analysis performed here allowed us to identify a
positive correlation between the genotype TT and the susceptibil-
ity to viral infections. Cats harboring the TT genotype are more
likely to be infected by FIV and/or FELV. No other polymorphism
was signiﬁcantly associated with infection. In contrast, when hap-
lotypes were analyzed, none showed signiﬁcant correlation to
infection. This result can be explained by the effect of the associa-
tion of polymorphisms. The haplotype is the combination of the six
polymorphic regions in the locus analyzed here for the samechromosome. Therefore, the susceptibility to virus infection is
subdivided among six different SNPs. Haplotypes containing T
may not be associated with viral infection due to the effect of the
other polymorphisms of the haplotype. In addition, the dose of
the allele may inﬂuence the correlation because only individuals
harboring T in homozygosis were signiﬁcantly associated with
viral infections.
In conclusion, it would be interesting to perform further studies
with a larger number of individuals so that the data presented in
this work can be corroborated. In addition, it would be of great
interest to evaluate the in vitro effects of these compounds in rela-
tion to the restrictive role of the protein.6. Conclusions
The APOBEC3 family of proteins encodes antiviral restriction
factors that are well preserved and that are present in a wide range
of mammalian species. The study of the interactions between these
proteins and retroviruses allows a better understanding about the
biology of these viruses and can then contribute to their control. By
studying the variation in the sequence of nucleotides in the feline
A3H gene, six polymorphisms were found within the second trans-
lated exon of the gene. Among the polymorphisms found, the SNP
A65S (A65I) was positively correlated with an increased suscepti-
bility to infection by FIV and/or FeLV. The analysis of the haplo-
types formed by these six SNPs allowed the description of ten
combinations, and ‘‘GGGGCC’’ showed a signiﬁcant correlation
with the absence of viral infection.
Importantly, this is the ﬁrst study in which the main focus was
the search for polymorphisms in the feline A3H gene by the
sequencing of several samples of FIV- and/or FeLV-infected or
non-infected domestic cats. In addition, we also describe a
correlation between different polymorphisms in this gene and
the susceptibility to retroviral infection.Acknowledgements
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